Pacira BioSciences Inc
PCRX
Market Cap$1.47B
Close$
$69.80
126.5% upside
Current Fair Value
126.5% upsideUndervalued by 126.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.47 Billion |
|---|---|
| Enterprise Value | $1.66 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $1.32 |
| Beta | 0.48 |
| Outstanding Shares | 46,546,148 |
| Avg 30 Day Volume | 964,678 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 20.81 |
|---|---|
| PEG | -14.26 |
| Price to Sales | 2.2 |
| Price to Book Ratio | 1.62 |
| Enterprise Value to Revenue | 2.44 |
| Enterprise Value to EBIT | 17.78 |
| Enterprise Value to Net Income | 23 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 0.58 |
Revenue Sources
No data
ESG Score
No data